NOTICE: Labnodes will be unavailable on Sunday March 4th for scheduled maintenance from 6-11AM central time.

Project Leader: Valentina Kon, M.D.

Co-Investigator: Patricia Yancey, Ph.D.

Statistician: Ayumi Kamina Shintani, Ph.D.

Consultant: Sergio Fazio, M.D., Ph.D.

Keywords: HDL

Category
Page
Record History
Added on January 23, 2012 at 1:16 PM by Brand, Dominique
Modified on January 23, 2012 at 1:27 PM by Brand, Dominique
Shared with (contributions)
PCEN: Projects Master

Although chronic kidney disease (CKD) causes dyslipidemia, its pattern does not necessarily fit into recommendations for therapeutic interventions in the general population and belies profound disturbances in the lipid metabolism and function. These studies will determine the mechanisms and thus potential therapeutic targets by which high density lipoprotein (HDL) disrupts basic biological processes that underlie a host of abnormalities that plague children with CKD, including cardiac disease, hypertension, impaired inflammatory response.